vorinostat has been researched along with Postural Orthostatic Tachycardia Syndrome in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Postural Orthostatic Tachycardia Syndrome: A syndrome of ORTHOSTATIC INTOLERANCE combined with excessive upright TACHYCARDIA, and usually without associated ORTHOSTATIC HYPOTENSION. All variants have in common an excessively reduced venous return to the heart (central HYPOVOLEMIA) while upright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, AW | 1 |
| Ziemann, M | 1 |
| Corcoran, SJ | 1 |
| K N, H | 1 |
| Okabe, J | 1 |
| Rafehi, H | 1 |
| Maxwell, SS | 1 |
| Esler, MD | 1 |
| El-Osta, A | 1 |
1 other study available for vorinostat and Postural Orthostatic Tachycardia Syndrome
| Article | Year |
|---|---|
Topics: Epigenesis, Genetic; Female; Gene Silencing; HeLa Cells; Histone Deacetylase Inhibitors; Humans; Mal | 2017 |